AFC Gamma, Inc.

Q2 2024 Earnings Conference Call

8/7/2024

spk00: Good morning, and welcome to Advanced Flower Capital's second quarter 2024 earnings call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session, and instructions will be given at that time. As a reminder, this call is being recorded. I would now like to turn the call over to Gabriel Katz, Chief Legal Officer. Please go ahead.
spk04: Good morning, and thank you all for joining AFC's earning call for the quarter ended June 30, 2024. I'm joined this morning by Daniel Neville, our Chief Executive Officer, Robin Tannenbaum, our President, and Brandon Hetzel, our Chief Financial Officer. Before we begin, I would like to note that this call is being recorded. Replay information is included in our July 15, 2024 press release and is posted on the investor relations portion of AFC's website at advancedflowercapital.com, along with our second quarter earnings release and investor presentation. Today's conference call includes forward-looking statements and projections that reflect the company's current views with respect to, among other things, anticipated market developments, portfolio yield and financial performance in 2024 and beyond. These statements are subject to inherent uncertainties in predicting future results. Please refer to AFC's most recent periodic filings with the SEC for certain conditions and significant factors that could cause actual results to differ materially from these forward-looking statements and projections. During this call, we will refer to distributable earnings, which is a non-GAAP financial measure. Reconciliations to net income, the most comparable GAAP measure, can be found in AFC's earning release and investor presentation on AFC's website. The format for today's call is as follows. Robin will start by discussing our spinoff. Then Dan will provide an overview of our second quarter 2024 performance and an update on our portfolio. Brandon will then conclude with a summary of our financial results, and we will then open the line for Q&A. With that, I will now turn the call over to our president, Robin Tannenbaum.
spk05: Thanks, Gabe, and good morning to all our investors and analysts that have joined us today. We are excited to announce that following the successful spinoff of our commercial real estate portfolio on July 9th, 2024, ASC has now fully transitioned to being a pure play cannabis lender. This strategic move allows us to focus solely on the cannabis sector. We believe that this positions us to more effectively capitalize on the opportunities in the cannabis market by concentrating our lending efforts on one industry. Additionally, this should allow us to target specific investor bases more effectively. Today, we are reporting on our second quarter results, which were pre-spin and include results from both the cannabis and commercial real estate lending portfolio. I'll now turn it over to Dan to discuss our second quarter results and some milestones we've achieved.
spk02: Thanks, Robin, and good morning. This quarter was marked by strong performance and several key achievements in our portfolio management and origination efforts. I'll start my remarks with a brief overview of results and the spinoff, then turn to portfolio management and origination followed by commentary on the state of the industry and capital markets before concluding. For the second quarter, AFC generated distributable earnings of 56 cents per basic weighted average share of common stock. As a reminder, distributable earnings is the primary metric the Board of Directors considers when declaring AFC's quarterly dividend. The Board declared a fifth consecutive 48-cent dividend, which was paid on July 15, 2024, to shareholders of record as of June 24, 2024. Also, in connection with the spinoff, the Board declared a special dividend of 15 cents, which was paid on July 15, 2024, to shareholders of record as of July 8, 2024. Since going public, we have generated distributable earnings that met or exceeded our dividend each quarter and paid out $6.65 in dividends per share. Going forward, the Board of Directors plans to continue to declare quarterly dividends on its normal cadence. When I joined AFC last November, I said that my three key priorities were to one, reduce exposure to underperforming credits through active portfolio management, two, to reinvigorate the origination engine, and three, to enhance our underwriting. Since then, we've made significant progress on each priority highlighted by a successful quarter with several notable loan exits. I'm extremely pleased to announce that in June, we successfully exited our largest credit facility, an $84 million loan to subsidiary of public company H. During our last earnings call, we highlighted that the borrower failed to make its April interest payment in May. Less than one month later, we sold the loan to a third party at par plus accrued, including default interest. This outcome was the result of months of very active portfolio management by the AFC team and generated a 19.9% internal rate of return over the life of the loan. This exit underscores our commitment to generating strong returns for our shareholders and taking a hands-on approach to managing complex credits. I'm also excited to report that in May, Private Company C made a final prepayment on its $24 million loan via excess cash flow sweeps, with the last $3.5 million prepaid this past quarter. This exit generated an impressive 25.5% IRR over the life of the loan. Additionally, in prior quarters, we noted that Private Company B within receivership following the $19 million loan maturing in September, 2023. We are pleased to announce that in June, we sold our loan at par plus accrued, including exit fees. Concurrent with the sale, we provided a $15 million loan to the purchasers to finance a portion of the acquisition secured by the same collateral. Our current portfolio has a weighted average yield to maturity of 19%. And as you can see from these two exits, we have recently generated an IRR at or above the weighted average yield to maturity on certain credit facilities. We will look to redeploy this capital into solid credits at attractive yields while also further diversifying our portfolio. As of June 30th, 2024, we had $1.94 per share in unrealized losses and CECL reserves. The positions we exited this quarter had CECL reserves and unrealized losses of 29 cents per share associated with them. By selling these positions at par, the 29 cents per share of reserves and unrealized losses were added back to book value. We believe we are appropriately reserved today. And while we have generated positive outcomes today, we will continue to be laser focused on actively managing the portfolio to unlock additional value for our shareholders. Subsidiary of private company G continues to make steady progress. Since we entered into the forbearance agreement in March 2024, the borrower has infused $3 million of additional equity capital and has paid over $3.9 million of interest to AFC. Additionally, there is significant accrued interest on this loan, which, if paid in cash, could enhance our returns. With the experienced operators we have put in place, we continue to see improved performance at the borrower's Pennsylvania and New Jersey operations. In just over three months, the New Jersey cultivation facility has gone from less than 25% planted without CO2 to fully planted with CO2 fully operational, and we expect the lab and kitchen to be online sometime in the fourth quarter. As a result, we expect a significant uptick in biomass produced in one of the tightest wholesale markets in the country. Similarly, in Pennsylvania, the operating partner has driven a remarkable turnaround in the stores, with sales tripling from the bottom. We are very happy with the progress so far and expect New Jersey wholesale to be firing on all cylinders by the end of the year. On the origination front, we are making substantial progress towards our target of $100 million for 2024. and are confident in meeting or exceeding this target. Year to date, we have closed three deals totaling $57.3 million with two additional deals in documentation, which would bring us close to our $100 million target. Our current cannabis pipeline is steadily growing and stands at $346 million. During the quarter, we were pleased to provide a senior secured credit facility to private company one of the leading brands in the edible space. We are excited to support their growth as they expand further into the East Coast and Midwest. This transaction demonstrates our ability to provide flexible and tailored financing solutions to meet the unique requirements of our borrowers at all stages of their growth. I'd now like to provide some commentary on the industry before concluding my remarks. The march toward legalization continued yesterday with the launch of adult youth sales in Ohio. Ohio was a $500 million medical market with a very low medical patient penetration. Pennsylvania has a similar population with a medical program more than triple in size at 1.5 billion. As a result of this low penetration, we expect to see a strong flip for existing players including a few of our borrowers. The start of AU sales in Ohio, the potential for Florida and Pennsylvania to flip in the next two years, and the startup of de novo medical programs in Alabama and Kentucky drive our optimism around the industry growth, and more importantly, the increasing demand for capital over the coming years. Turning to the capital markets, two large Large Tier 2 public companies recently refinanced existing term loans, each at an all-in yield of a little over 14%. One of these borrowers refinanced 2021 vintage debt at a 9.8% yield, resulting in a 400 basis point increase in the spread versus where debt was raised in 2021. This increase in yields is in part due to industry performance since 2021, but is also due to the increase in rates generally over the past two years. All else being equal, if larger public companies are issuing at 14%, then private companies should have wider yields. With that said, we are happy with the returns we generate and are going to focus on moving up the quality curve while still targeting mid- to high-teens IRRs as opposed to reaching on-yield. Between these refinancings, adult use and medical expansions, and the recent uptick in M&A activity, we expect demand for debt capital to remain robust and the supply-demand imbalance for that capital to persist. With the spinoff of our commercial real estate business, We are now fully focused on lending to the cannabis industry. We remain confident in our ability to continue to deliver strong financial performance and generate value for our shareholders. We are well positioned to capitalize on the growing opportunities in the industry and believe the capital supply demand imbalance will allow us to deliver attractive risk adjusted returns. With that, I'll turn it over to Brandon to discuss our financial results in more detail. Thank you, Dan.
spk03: As a reminder, all Q2 figures discussed are pre-spend. For the quarter ended June 30, 2024, we generated net interest income of $18.4 million and distributable earnings of $11.4 million, or $0.56 per basic weighted average common share, and had a GAAP net income of $16.4 million or 80 cents per basic weighted average common share. As previously mentioned, we believe providing distributable earnings is helpful to shareholders in assessing the overall performance of AFC's business. Distributable earnings represents net income computed in accordance with GAAP, excluding non-cash items such as stock compensation expense, any unrealized gains or losses, provision for current expected credit losses, also known as CECL, taxable resubsidiary income or loss net of dividends, and other non-cash items recorded in net income or loss for the period. We ended the second quarter of 2024 with $335.4 million of principal outstanding spread across 14 loans. As of August 1, 2024, our portfolio consisted of $287.1 million of principal outstanding across 12 loans following the completion of the spinoff of our CRE portfolio. The weighted average portfolio yield to maturity, which is measured for each loan over the life of such loan, was approximately 19% as of June 30, 2024 and August 1, 2024. As of June 30, 2024, we had total assets of $458 million, including cash and cash equivalents of $170.3 million, with the majority of our cash currently earning interest of approximately 4.5% to 5.3%. We had $35 million drawn on our line of credit, which was subsequently repaid in full on July 1, 2024. Our line of credit provides us with up to $60 million in available funds that can be drawn as needed. Both the credit line and the unsecured bonds remain at AFC following this spinoff. As of June 30, 2024, the CECL reserve was $25.2 million, or approximately 9.1% of our loans at carrying value, which decreased $6.2 million from the March 31, 2024 reserve of $31.4 million. During the second quarter, we also had an increase in our unrealized losses on loans at fair value of $1.4 million, increasing the current total unrealized loss included in our balance sheet to $15 million. As of June 30, 2024, our total shareholder equity was $314.3 million, and our book value per share was $15.21. After the quarter ended, we completed the spinoff of our CRE portfolio, which included the distribution of approximately $115 million of loans in cash, or approximately $5.56 of book value per share. On July 15, 2024, AFC paid a dividend of $0.48 per common share for the second quarter to shareholders of record as of June 24, 2024. Additionally, we paid a special dividend of $0.15 per common share on July 15, 2024, to shareholders of record as of July 8, 2024. As a reminder, on an annual basis, our dividend policy is to pay between 85% and 100% of distributable earnings over the year. With regards to the effect of the spinoff on the cost basis of ASC shares, we will post a form on our website discussing this treatment in the near future. However, the final determination cannot be finalized until the end of the year and will be reflected on your 1099-DIB sent after the year end. With that, I will now turn it back over to the operator to start the Q&A.
spk00: Thank you. To ask a question, please press star 11 on your telephone and wait for your name to be announced. To withdraw your question, please press star 11 again. Please stand by while we compile the Q&A roster. Our first question comes from the line of Pablo Zwanek with Zwanek & Associates. Your line is now open.
spk01: Good morning, everyone. Maybe the first question for Dan, if you can just, I know this is an earnings call, but if you can just give us more background and color in terms of what you have accomplished in the company since you joined, what you have focused on, that would be helpful to start with that. Thank you.
spk02: Yeah, absolutely, Pablo. Thanks for the question. Tad Piper- The three priorities that I had when I came in were first to manage underperforming credit, I think, as you've seen from the activity this quarter, as well as activity and prior quarters, we made a lot of progress on that front. getting capital back and being able to recycle that capital into new operators in the space with attractive credit profiles and attractive yields. So over the last nine months, that has been a lot of work and a lot of that work was ongoing prior to myself joining, but we've made very significant progress. The job's not finished on that front. There's still a little bit more work to do, but I think overall we're very pleased with the progress that we've made. Secondly was focused on origination. AFC had been more focused on commercial real estate for about the prior 18 to 24 months of me joining and hadn't been as active in the cannabis space given some of the vintages that were coming out and the performance in the market that we were seeing. We're now back in the market and have $57 million of origination today. We're in active dialogues with, I think, a great vintage of quality operators that are sitting in our pipeline and very happy to be back on the offensive and deploying existing capital as well as some of the capital that we've got back from some of the portfolio management efforts. And then finally is just being very active on the underwriting side of things. I think the existing team, Len and Robin, as well as everyone else over at the AFC side of things, has a wealth of experience on the direct lending, structuring, and credit side of things, and provides a very helpful top-down lens on the underwrite. and given my background on the operations side of things during my time at Ascend, that allows me to come in and do the bottoms-up evaluation of growth facilities, retail sites, just adding a little bit more context to the underwrite and looking at each operation on a de novo basis. something that, you know, I have a decent amount of experience or a wealth of experience from my five years at Ascend and the scars that I have on my back working to help build that business and is proving very useful as we're looking at new credits in the portfolio.
spk01: Thank you. That's great color. Look, I'm just one last question. Obviously I hear you in terms of the demand supply imbalance, right? Which, which is a good backdrop for, for the industry and for companies like yourself. But any changes that you're seeing on the supply side, right? It seems that, you know, maybe it's more regional banks, whether there's more private debt capital out there, whether, you know, when these companies are refinancing, we've seen four or five recently, there seems to be more options or that's not the case necessarily. Thank you.
spk02: Yeah, I think on the refinancing side of things, it's primarily the same players. I believe somewhere around three quarters of the participants in one of the refinancings were an existing player. The other recent tier two financing was a player that's been active in the space previously and someone that we see from time to time. We're seeing a lot of the same folks out there, to be quite honest. I think on the regional bank side of things, we're not really running into those players much at all. One of those competitors is public. I think they've done $14 million into the space year to date this year. And some of the other players there are pulling back. So it's just not something we're running into, I think. Our borrowers value, you know, the flexible, dynamic solutions that we can provide. We're very much a bespoke credit underwriter and capital provider. And each credit and each credit facility is a bit unique, obviously, with the standard protections that we need to protect our investment. But, you know, I think we're seeing a lot of people value that flexibility that we can provide relative to what I think is more of a cookie cutter approach on the regional banking side of things at lower LTBs.
spk01: Thank you. Look, I want to add one more. I don't know if you're in a position to give any color in terms of a pro forma book, what it looks like, what the new dividend could be range-wise. I don't know. Any color you can provide in terms of pro forma numbers. Thanks.
spk05: Sure. So from a dividend standpoint, I think as Dan said in his remarks, the board will declare their dividend on the normal cadence. If you think about, we've declared a 48-cent dividend for the last five quarters, I believe. And if you just think about the spinoffs, we kept about two-thirds of assets, and we spun off one-third of the assets. In terms of pro forma book, I think Brandon gave you on the Q2 number, right, what we spun off. So we spun off approximately $5.56 of book value per share. Thank you.
spk00: Thank you. As a reminder, to ask a question at this time, please press star 1-1 on your touchtone telephone. And I'm currently showing no further questions at this time. This does conclude today's conference call. Thank you for your participation. And you may now
Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-